Placebo response in the prophylaxis of migraine: A meta‐analysis
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background:Migraine constitutes a good model for the study of placebo response. It is a well‐defined disease, affects a large population and a great number of clinical trials have been performed, which have given homogeneous outcomes. Aim:The aim of this meta‐analysis is to evaluate the placebo response rate in migraine prophylaxis in all published clinical trials since 1988 and to estimate the influence of study design in response variability. Methods:A computer‐based information search was conducted on the Medline database. The outcomes studied were patients who improved (reduction in migraine attacks of 50% or more); attacks per month, and patients with adverse events. Study design and countries in which the study was carried out were also analysed. The meta‐analysis was computed using the Mantel–Haenszel test. Results:In the final analysis, 32 papers were considered. The pooled estimate of the placebo response (patients who improved) was 21%. The placebo response rates were significantly higher in studies with a parallel design than those in cross‐over studies (p<0.01). This response was also higher in European studies than in those performed in North America (p<0.001). Adverse events occurred in 30% of the patients who took a placebo, and the percentage of patients with adverse events was significantly higher in the North American studies than in those conducted in Europe (p<0.01). Conclusion:These data reinforce the need to consider the placebo effect when ascertaining the true therapeutic effect of any drug, as well as to design any clinical trial in the prophylaxis of migraine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing
Walsh, B. T., Seidman, S. N., Sysko, R., & Gould, M. (2002) · JAMA · doi:10.1001/jama.287.14.1840 · Cited by 1,109 · cited 1×
“…(2005) Chronic fatigue syndrome Su et al. (2004) Crohn’s disease 21 McCall et al. (2003) Primary insomnia 5 Chvetzoff and Tannock (2003) Cancer 37 Walsh et al. (2002) Major depressive disorder 75 Averbuch and Katzper (2003) Post-third molar extraction dental pain 16 Joyce et al. (2000) Asthma…”
BackgroundThe placebo effect in irritable bowel syndrome trials: a meta‐analysis1
Patel, S. M., Stason, W. B., Legedza, A., Ock, S. M., Kaptchuk, T. J., Conboy, L., Canenguez, K., Park, J. K., Kelly, E., Jacobson, E., et al. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00650.x · Cited by 285 · cited 1×
“…is the information given to the patients, Table 2 Placebo groups results in several clinical conditions Study/year Pathology Numbe clinical Patel et al. (2005) Irritable bowel syndrome 45 Cho et al. (2005) Chronic fatigue syndrome Su et al. (2004) Crohn’s disease 21 McCall et al. (2003)…”
BackgroundSu, C., Lichtenstein, G. R., Krok, K., Brensinger, C. M., & Lewis, J. D. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.024 · Cited by 212 · cited 1×
“…clinical conditions Study/year Pathology Numbe clinical Patel et al. (2005) Irritable bowel syndrome 45 Cho et al. (2005) Chronic fatigue syndrome Su et al. (2004) Crohn’s disease 21 McCall et al. (2003) Primary insomnia 5 Chvetzoff and Tannock (2003) Cancer 37 Walsh et al. (2002) Major…”
Background
Cited by
Dodick, D. W., Turkel, C. C., DeGryse, R. E., Aurora, S. K., Silberstein, S. D., Lipton, R. B., Diener, H., & Brin, M. F. (2010) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01678.x · Cited by 994
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
Dodick, D. W., Ashina, M., Brandes, J. L., Kudrow, D., Lanteri-Minet, M., Osipova, V., Palmer, K., Picard, H., Mikol, D. D., & Lenz, R. A. (2018) · Cephalalgia · doi:10.1177/0333102418759786 · Cited by 566
New Insights into the Placebo and Nocebo Responses
Enck, P., Benedetti, F., & Schedlowski, M. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.030 · Cited by 531
Reuter, U., Goadsby, P. J., Lanteri-Minet, M., Wen, S., Hours-Zesiger, P., Ferrari, M. D., & Klatt, J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32534-0 · Cited by 457
Dodick, D. W., Goadsby, P. J., Silberstein, S. D., Lipton, R. B., Olesen, J., Ashina, M., Wilks, K., Kudrow, D., Kroll, R., Kohrman, B., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70209-1 · Cited by 372
Aurora, S. K., Winner, P., Freeman, M. C., Spierings, E. L., Heiring, J. O., DeGryse, R. E., VanDenburgh, A. M., Nolan, M. E., & Turkel, C. C. (2011) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01990.x · Cited by 295
Prophylaxis of migraine headaches with riboflavin: A systematic review
Thompson, D. F., & Saluja, H. S. (2017) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12548 · Cited by 101
Tao, K.-M., Li, X.-Q., Zhou, Q.-H., Moher, D., Ling, C.-Q., & Yu, W.-F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027611 · Cited by 101
de Roos, N. M., van Hemert, S., Rovers, J. M. P., Smits, M. G., & Witteman, B. J. M. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.57 · Cited by 89
Metadata
- Authors
- Macedo, A., Baños, J., & Farré, M.
- Venue
- European Journal of Pain
- Publisher
- Wiley
- Published
- 2008-01
- Volume
- 12
- Issue
- 1
- Pages
- 68-75
- ISSN
- 1090-3801 (ISSN-L)
- 1532-2149
- OpenAlex
- W2039070405
- Cited by
- 124
- References
- 3
- FWCI
- 4.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.